UK markets closed
NIKKEI 225
26,173.98 -397.89 (-1.50%) HANG SENG
17,250.88 -609.43 (-3.41%) CRUDE OIL
81.77 -0.38 (-0.46%) GOLD FUTURES
1,666.30 -3.70 (-0.22%) DOW
29,683.74 +548.75 (+1.88%) BTC-GBP
17,980.27 +362.02 (+2.05%)
Adverum Biotechnologies, Inc. (0HA3.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:23PM BST
| Previous close | 1.0300 |
| Open | 0.9673 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.9673 - 0.9673 |
| 52-week range | 0.9673 - 0.9673 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 776,298 |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Here's Why We're Watching Adverum Biotechnologies' (NASDAQ:ADVM) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Adverum (ADVM) Doses First Patient in the Mid-Stage wAMD Study
Adverum (ADVM) initiates dosing in the phase II LUNA study, currently investigating its lead product candidate ixoberogene soroparvovec for wet age-related macular degeneration.
- Simply Wall St.
Quite a few insiders invested in Adverum Biotechnologies, Inc. (NASDAQ:ADVM) last year which is positive news for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
© 2022 Yahoo. All rights reserved.
